Enzon Pharmaceuticals, Inc. (ENZN)

Enzon Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 16, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3	12	7	18	25	18
Market Cap Growth	-54.65%	66.86%	-62.07%	-27.98%	37.89%	102.39%
Enterprise Value	4	9	4	16	20	13
Last Close Price	0.04	0.16	0.09	0.25	0.34	0.25
PE Ratio	-	-	70.85	-	-	-
Forward PE	-	5.89	5.89	5.89	5.89	5.89
PS Ratio	-	445.57	-	704.04	36.26	354.51
PB Ratio	0.07	0.26	0.15	0.40	0.54	0.39
P/TBV Ratio	-	3.85	1.98	5.37	5.22	2.51
P/OCF Ratio	-	10.33	5.32	-	-	-
EV/Sales Ratio	-	347.23	-	597.27	27.83	252.38
Asset Turnover	-	0.00	-	0.00	0.02	0.00
Quick Ratio	80.10	27.93	27.43	27.65	118.29	116.93
Current Ratio	80.86	28.10	27.62	27.89	118.50	117.07
Return on Equity (ROE)	-5.36%	1.70%	2.99%	-0.40%	-0.99%	-4.87%
Return on Assets (ROA)	-1.87%	-1.75%	-1.37%	-1.35%	-0.61%	-2.98%
Return on Capital (ROIC)	-1.89%	-1.81%	-1.42%	-1.38%	-0.62%	-3.03%
Return on Capital Employed (ROCE)	-3.20%	-2.90%	-2.30%	-2.20%	-1.00%	-2.70%
Earnings Yield	-121.11%	6.72%	19.78%	-1.02%	-1.85%	-7.11%
Payout Ratio	-	163.88%	92.86%	-	-	-
Buyback Yield / Dilution	-	-	-	-	-45.23%	-15.57%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.